
Myeloma Paper of the Day, April 12th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: The oligosaccharyltransferase complex is an essential component of myeloma plasma cells and its targeting can suppress myeloma cell growth, induce cell-cycle arrest, and apoptosis, and work synergistically with bortezomib.”
“The oligosaccharyltransferase complex is an essential component of multiple myeloma plasma cells”
Authors: Hong Phuong Nguyen, Enze Liu, Anh Quynh Le, Mahesh Lamsal, Jagannath Misra, Sankalp Srivastava, Harikrishnan Hemavathy, Reuben Kapur, Mohammad Abu Zaid, Rafat Abonour, Ji Zhang, Ronald Wek, Brian Walker, Ngoc Tung Tran.
More posts featuring Robert Orlowski.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023